← All Purple Biotech LTD filings

Purple Biotech LTD F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
PPBT
Purple Biotech LTD
F-1: Purple Biotech Launches $6M Public Offering of ADSs and Warrants
Purple Biotech Ltd. announced a public offering of up to 2,702,702 American Depositary Shares and accompanying warrants, aiming to raise approximately $5.18 million in net proceeds for oncology therapeutic development and general working capital.
NASDAQ
PPBT
Purple Biotech LTD
F-1: Purple Biotech Files for Resale of 11.7 Million ADSs Following Warrant Exercise Transaction
Purple Biotech is registering for resale up to 11,661,364 American Depositary Shares (ADSs) issuable upon the exercise of warrants by selling shareholders.